HBV-IN-47

• UNSPSC Description:

  HBV-IN-47 (compound 4a) is a capsid assembly regulator with inhibitory activity against hepatitis B virus (HBV). HBV-IN-47 exhibits strong anti-HBV activity in HepAD38 cells with low toxicity (EC50=0.24 μM). HBV-IN-47 can be used for the study of chronic hepatitis B (CHB)[1].

• Target Antigen:

  HBV

• Type:

  Reference compound

• Related Pathways:

  Anti-infection

• Applications:

  COVID-19-anti-virus

• Field of Research:

  Infection

• Assay Protocol:

  https://www.medchemexpress.com/hbv-in-47.html

• Smiles:

  O=C(NC1=CC(F)=C(F)C(F)=C1)C2=CC(S(=O)(NC3CCCC3)=O)=CC4=C2OCCO4

• Molecular Weight:

  456.44

• References & Citations:

  [1]M Liang, et al. "Design, synthesis and anti-HBV activity study of novel HBV capsid assembly modulators." Bioorganic & Medicinal Chemistry Letters (2024): 129913.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported